CompletedNot Applicable

EP Combined With RFA for Ampullary Neoplasms With Intraductal Biliary Extension

China12 participantsStarted 2013-02-10

Plain-language summary

Endoscopic papillectomy is the preferred approach for management of ampullary adenomas. Endobiliary radiofrequency ablation (RFA) is an ablative therapy that has been used to treat malignant biliary strictures. The aim of this study was to evaluate the safety and efficacy of endoscopic papillectomy combined with endobiliary RFA for ampullary neoplasms with intraductal biliary extension.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with histologically proven ampullary adenoma or adenocarcinoma with intraductal biliary extension ≥1cm who were deemed medically unfit for surgery or declined surgery Exclusion Criteria: * pancreatic invasion, lymph node invasion, distant metastasis, or coagulopathy.

What they're measuring

Recurrence

Timeframe: one year

Trial details

NCT IDNCT05028465

SponsorFirst People's Hospital of Hangzhou

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-11-20

View on ClinicalTrials.gov More Ampullary Adenomas trials